Cargando…
Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer
INTRODUCTION: GATA binding protein 3 (GATA3) is a regulator of mammary luminal cell differentiation, and an estrogen receptor (ER) associated marker in breast cancer. Tumor suppressor functions of GATA3 have been demonstrated primarily in basal-like breast cancers. Here, we focused on its function i...
Autores principales: | Cohen, Helit, Ben-Hamo, Rotem, Gidoni, Moriah, Yitzhaki, Ilana, Kozol, Renana, Zilberberg, Alona, Efroni, Sol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303202/ https://www.ncbi.nlm.nih.gov/pubmed/25410484 http://dx.doi.org/10.1186/s13058-014-0464-0 |
Ejemplares similares
-
hsa-miR-9 controls the mobility behavior of glioblastoma cells via regulation of MAPK14 signaling elements
por: Ben-Hamo, Rotem, et al.
Publicado: (2015) -
SENP5 mediates breast cancer invasion via a TGFβRI SUMOylation cascade
por: Cashman, Rivki, et al.
Publicado: (2014) -
Resistance to paclitaxel is associated with a variant of the gene BCL2 in multiple tumor types
por: Ben-Hamo, Rotem, et al.
Publicado: (2019) -
Breast cancer is marked by specific, Public T-cell receptor CDR3 regions shared by mice and humans
por: Gordin, Miri, et al.
Publicado: (2021) -
Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression
por: Ben-Hamo, Rotem, et al.
Publicado: (2011)